Prognostic Stage 2 Breast Cancer AJCC v8 Completed Phase 1 Trials for Interferon alfa-2b (DB00105)

Also known as: Prognostic Stage II Breast Cancer AJCC v8

DBCOND0140767 (Prognostic Stage 2 Breast Cancer AJCC v8)Completed1 IdentifierTitlePurposeDrugs
NCT04081389Chemokine Modulation Therapy and Standard Chemotherapy Before Surgery for the Treatment of Early Stage Triple Negative Breast CancerTreatment